Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Program effective Date: Jun 05, 2017
Program effective Date: Oct 24, 2017
Program effective Date: Jul 11, 2017
Program effective Date: Dec 13, 2016
Program effective Date: Jul 27, 2016
Program effective Date: Aug 08, 2016
Program effective Date: Jan 18, 2017
Program effective Date: Sep 01, 2016
Program effective Date: Aug 23, 2017
Program effective Date: Jul 27, 2016